Skip to Main Content
Try STAT+ TODAY
Trending:
First Opinion
Coronavirus
Biotech
Pharma
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

Allergan and a Mohawk tribe ask the Supreme Court to review their controversial patent deal

  • Ed Silverman

By Ed Silverman Jan. 15, 2019

Reprints
Pfizer Allergan
Richard Drew/AP

File this under: “If at first you don’t succeed …”

After being rebuffed by a federal appeals court last summer, Allergan (AGN) and the St. Regis Mohawk Tribe have asked the U.S. Supreme Court to decide a vexing question that was at the heart of a controversial maneuver to protect a best-selling eye medicine.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed covers the pharmaceutical industry.

Tags

Push to double up on Covid booster and flu…
Push to double up on Covid booster and flu shot may have a downside, experts caution
23andMe had devastating news about my health. I wish…
23andMe had devastating news about my health. I wish a person had delivered it
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
FDA: Ignore a pharma company’s deceptive racial equity argument…
FDA: Ignore a pharma company’s deceptive racial equity argument for keeping Makena, an ineffective preterm labor…
Health insurers are painting a misleading picture of Medicare…
Health insurers are painting a misleading picture of Medicare Advantage savings, experts say
Subject, not suspect: The new hazards of conducting clinical…
Subject, not suspect: The new hazards of conducting clinical research in the Dobbs era

Recommended Stories